A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity
Beatrice Cubitt(Scripps Research Institute), Juan Carlos de la Torre(Scripps Research Institute), Noel Southall(National Institutes of Health), Luis Martínez‐Sobrido(Texas Biomedical Research Institute), Emilio Ortiz-Riaño(University of Rochester Medicine), Benson YH. Cheng(University of Rochester Medicine), Charles D. Yeh(National Institutes of Health), Catherine Z. Chen(National Institutes of Health), Yu-Jin Kim(Kyung Hee University), Wei Zheng(Liaoning Cancer Hospital & Institute)
Cited by 19
Related Papers
The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis
|Immunity|2016|600
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
|The Lancet Microbe|2021|435